Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2025 Apr 3:1-20.
doi: 10.1159/000545605. Online ahead of print.

Türkiye Consensus Report on the Multidisciplinary Obesity Treatment in Adults

Alper Sonmez  1 , Fahri Bayram  2 , Oktay Banli  3 , Ibrahim Demirci  1 , Sinem Kiyici  4 , Meral Kucuk Yetgin  5 , Taner Bayraktaroglu  6 , Feray Akbas  7 , Halil Coskun  8 , Serhat Ocakli  9 , Nihat Aksakal  10 , Muhammed Taha Demirpolat  11 , Samet Yardimci  12 , Ferhat Cay  13 , Gokcem Yalin Kocamaz  2 , Dilek Yazici  14 , Ozgur Sevim  15 , Harun Karabacak  15 , Hasan Altun  16 , Zehra Yagmur Sahin Alak  17 , Ceren Iseri  18 , Asim Cingi  19 , Halil Ozguc  20 , Fatih Mehmet Avsar  21 , Mustafa Taskin  3 , Nihal Zekiye Erdem  22 , Aziz Sumer  23 , Mustafa Cesur  1 , Eren Halit Taskin  24 , Volkan Demirhan Yumuk  25
Affiliations
Practice Guideline

Türkiye Consensus Report on the Multidisciplinary Obesity Treatment in Adults

Alper Sonmez et al. Obes Facts. .

Abstract

Obesity is the world's most dangerous and rapidly growing health problem. Treating people living with obesity is not limited to the weight-loss process. They should also be followed up with a multidisciplinary approach to maintain the weight loss achieved. There is a lack of structural and functional standardization in obesity centers that undertake medical and surgical treatment. This consensus report, prepared by professional organizations for treating obesity, aimed to ensure that all obesity centers can perform standard patient management using evidence-based workflow diagrams. The report covers all the steps, starting from the initial evaluation process. It describes how to make treatment decisions jointly, defines the responsibilities of obesity councils, and designates the follow-up procedures of medically or surgically treated patients. The consensus report underlines that all healthcare professionals treating obesity are complementary. No discipline can achieve absolute success in treating people with obesity on its own. It is mandatory to implement a sustainable and practical collaboration based on current scientific evidence in treating and following up individuals with obesity.

Keywords: Bariatric surgery; Obesity; Obesity council; Obesity treatment.

PubMed Disclaimer

Conflict of interest statement

Alper Sonmez participated in advisory board meetings held by Novo Nordisk, Novartis, Eli Lilly, and Trispera. Fahri Bayram participated in clinical studies and advisory board meetings conducted by Novo Nordisk, Pfizer, AstraZeneca, and Boehringer and got honorarium from Econix, Sandoz, Eli Lilly, MSD, Medtronic, Trispera, Abbott, Sanovel, Sanofi, and Novartis. Sinem Kiyici engaged in advisory boards and lectures with Novo Nordisk, Trispera Pharma Solutions, Boehringer Ingelheim, AstraZeneca, Abbott, Novartis, and Sanofi and participated in clinical trial performed by Boehringer Ingelheim. Dilek Yazici engaged in advisory boards and lectures with Novo Nordisk, Lilly, Boehringer Ingelheim, and Sanofi. Zehra Yağmur Şahin Alak had congress support from Novo Nordisk, Servier, Science Pharmaceuticals, and Boehringer Ingelheim. Feray Akbaş got congress support from Sanovel, Menarini, and Novo Nordisk. Taner Bayraktaroglu gave lectures with Boehringer Ingelheim, Gen İlaç, Bilim İlaç and got research payment from Accelsiors. Mustafa Cesur participated in advisory board meetings held by Novo Nordisk, Abdi Ibrahim, and Trispera and got an honorarium from Servier and Novo Nordisk. Volkan Yumuk engaged in advisory boards and lectures with Novo Nordisk, Eli Lily, Rhythm, and Regeneron. Other authors declare that they have no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Edmonton Obesity Staging System [44]. Permission is obtained from Professor Arya Sharma by personal communication.
Fig. 2.
Fig. 2.
Frequency of follow-up visits for patients under medical treatment.
Fig. 3.
Fig. 3.
Frequency of follow-up visits for patients after surgical treatment.
See this image and copyright information in PMC

References

    1. Bray GA, Kim KK, Wilding JPH; World Obesity Federation . Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715–23. - PubMed
    1. Jastreboff AM, Kotz CM, Kahan S, Kelly AS, Heymsfield SB. Obesity as a disease: the obesity society 2018 position statement. Obesity. 2019;27(1):7–9. - PubMed
    1. Mehrabi F, Mahani F, Cheraghi L, Kheradmand A, Azizi F, Amiri P. Health-related quality of life in those with persistent or transient obesity phenotypes during two decades: tehran lipid and glucose Study. Obes Facts. 2023;16(3):273–81. - PMC - PubMed
    1. Abdelaal M, le Roux CW, Docherty NG. Morbidity and mortality associated with obesity. Ann Transl Med. 2017;5(7):161. - PMC - PubMed
    1. Cawley J, Biener A, Meyerhoefer C, Ding Y, Zvenyach T, Smolarz BG, et al. Direct medical costs of obesity in the United States and the most populous states. J Manag Care Spec Pharm. 2021;27(3):354–66. - PMC - PubMed

Publication types

LinkOut - more resources